Folylpolyglutamate Synthetase Gene Transcription is Regulated by a Multiprotein Complex that Binds the TEL-AML1 Fusion in Acute Lymphoblastic Leukemia

被引:10
|
作者
Leclerc, Guy J. [1 ]
Sanderson, Christopher [1 ]
Hunger, Stephen [2 ]
Devidas, Meenakshi [3 ,4 ]
Barredo, Julio C. [1 ,5 ,6 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Pediat Hematol & Oncol, Miami, FL 33101 USA
[2] Childrens Hosp, Denver, CO 80218 USA
[3] Univ Florida, Coll Med, Childrens Oncol Grp, Gainesville, FL USA
[4] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA
[5] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA
[6] Univ Miami, Miller Sch Med, UM Sylvester Comprehens Canc Ctr, Miami, FL 33101 USA
关键词
FPGS; TEL-AML1; Rb/E2F; Chromatin remodeling; ALL; leukemia; HDAC1; methotrexate; METHOTREXATE POLYGLUTAMATES; B-LINEAGE; T-LINEAGE; EXPRESSION; CELL; ACCUMULATION; TEL; CHEMOTHERAPY; COMBINATION; MECHANISMS;
D O I
10.1016/j.leukres.2010.05.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute Lymphoblastic Leukemia (ALL) non-random fusions influence clinical outcome and alter the accumulation of MTX-PGs in vivo. Analysis of primary ALL samples uncovered subtype-specific patterns of folate gene expression. Using an FPGS-luciferase reporter gene assay, we determined that E2A-PBX1 and TEL-AML1 expression decreased FPGS transcription. ChIP assays uncovered HDAC1, AML1, mSin3A, E2F, and Rb interactions with the FPGS promoter region. We demonstrate that FPGS expression is epigenetically regulated through binding of selected ALL fusions to a multiprotein complex, which also controls the cell cycle dependence of FPGS expression. This study provides insights into the pharmacogenomics of MTX in ALL subtypes. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1601 / 1609
页数:9
相关论文
共 50 条
  • [31] TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia
    Avigad, S
    Kuperstein, G
    Zilberstein, J
    Liberzon, E
    Stark, B
    Gelernter, I
    Kodman, Y
    Luria, D
    Ash, S
    Stein, J
    Goshen, Y
    Yaniv, I
    Cohen, IJ
    Zaizov, R
    LEUKEMIA, 1999, 13 (03) : 481 - 483
  • [32] TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia
    S Avigad
    G Kuperstein
    J Zilberstein
    E Liberzon
    B Stark
    I Gelernter
    Y Kodman
    D Luria
    S Ash
    J Stein
    Y Goshen
    I Yaniv
    IJ Cohen
    R Zaizov
    Leukemia, 1999, 13 : 481 - 483
  • [33] TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukaemia (ALL).
    Seeger, K
    Buchwald, D
    Beyermann, B
    Adams, HP
    Kochling, J
    Schmid, HJ
    Niemeyer, C
    Janka, G
    Henze, G
    BLOOD, 1997, 90 (10) : 2496 - 2496
  • [34] Detection of the der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia
    Kobayashi, H
    Satake, N
    Kaneko, Y
    LEUKEMIA & LYMPHOMA, 1997, 28 (1-2) : 43 - 50
  • [35] Protracted and variable latency of acute lymphoblastic leukaemia after TEL-AML1 gene fusion in utero.
    Wiemels, JL
    Ford, AM
    Van Wering, ER
    Postma, A
    Greaves, MF
    BLOOD, 1998, 92 (10) : 511A - 511A
  • [36] Treatment with VDLP induction chemotherapy in acute lymphoblastic leukemia with TEL-AML1 and TEL-ABL rearrangements
    Mao Shuting
    Liu Yufeng
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S33 - S33
  • [37] DETECTION OF TEL-AML1/TEL-ABL FUSION GENES USING A MULTI-FUSION GENE QRT-PCR SCREENING METHOD IN ACUTE LYMPHOBLASTIC LEUKEMIA
    Liu, Yufeng
    Zhang, Jingyu
    Mao, Shuting
    Su, Shufang
    Wei, Linlin
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S88 - S88
  • [38] TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan
    Lin, Pei-Chin
    Chang, Tai-Tsung
    Lin, Shiu-Ru
    Chiou, Shyh-Shin
    Jang, Ren-Chin
    Sheen, Jiunn-Ming
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2008, 24 (06): : 289 - 296
  • [39] Persistence of TEL-AML1 transcript in acute lymphoblastic leukemia in long-term remission
    Endo, C
    Oda, M
    Nishiuchi, R
    Seino, Y
    PEDIATRICS INTERNATIONAL, 2003, 45 (03) : 275 - 280
  • [40] Treatment with VDLP induction chemotherapy in acute lymphoblastic leukemia with TEL-AML1 and TEL-ABL rearrangements
    Mao Shuting
    Liu Yufeng
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S33 - S33